Devin Scannell
10xy.bsky.social
Devin Scannell
@10xy.bsky.social
Science. Markets. Skeets. Training my world model
Correct understanding of how genome evolution works
March 17, 2025 at 11:27 PM
"Prior to the enactment of Bayh–Dole, the U.S. government had accumulated 28,000 patents, but fewer than 5% of those patents were commercially licensed". @tracyalloway.bsky.social @weisenthal.bsky.social the Jones Act (in a good way) for US Biopharma: en.wikipedia.org/wiki/Bayh%E2...
Bayh–Dole Act - Wikipedia
https://en.wikipedia.org/wiki/Bayh–Dole_Act
March 11, 2025 at 12:31 AM
Sixteen novel cancer therapies were approved in the US in 2024. Surprisingly, they add an average of 3 months of incremental survival (vs 10-15 years lost) and benefit a median of just ~1600 patients.

My analysis of 2024 cancer approvals on Substack (7 mins): open.substack.com/pub/amodernp...
February 25, 2025 at 5:29 PM
Reposted by Devin Scannell
Excited to share PoET-2, our next breakthrough in protein language modeling. It represents a fundamental shift in how AI learns from evolutionary sequences. 🧵 1/13
February 11, 2025 at 2:30 PM
Reposted by Devin Scannell
The Genomic Code: The genome instantiates a generative model of the organism arxiv.org/abs/2407.15908 (revised version, following peer review)
January 17, 2025 at 4:31 PM
Reposted by Devin Scannell
new blogpost: What we learned about binder design from the Adaptyv competition blog.booleanbiotech.com/what-we-lear...
Boolean Biotech
blog.booleanbiotech.com
December 30, 2024 at 11:46 PM